Health Care: Drugs

Halozyme Therapeutics Inc (HALO: NASDAQ)

$9.46 n/a | n/a%
12/19/14 - 04:00 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
HALOSector Avg.S&P 500
n/a025.85
Price Performance History (% change):
3 Mo1 Yr3 Yr
-3.4694-36.33922.4919
GROWTH12 Mo3 YrCAGR
Revenue29.53.020.58
Net Income0.570
EPS0.32n/a
Earnings for HALO:
EBITDA-78.00
REVENUE54.80M
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $-0.14 $-0.13 $-0.66 $-0.39
Number of Analysts 4 1 5 5
High Estimate $-0.11 $-0.13 $-0.61 $-0.11
Low Estimate $-0.16 $-0.13 $-0.74 $-0.55
Prior Year $-0.19 $-0.22 $-0.74 $-0.66
Growth Rate (Year over Year) 27.63% 40.91% 10.81% 40.30%

Portfolios with HALO

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter